Jennifer Kao
Assistant Professor of Strategy
About
Jennifer Kao’s research interests lie in the economics of innovation and science, firm strategy and health care. Her work seeks to understand how information and regulation shape firms’ incentives to innovate. A recent project explores how publicly available scientific information shapes the rate, direction and profitability of innovation in the pharmaceutical industry. Other projects examine how drug approval regulation shapes firms’ market entry strategies.
Topics
6 Articles
Huge Spending — But Little Sharing of Research Results — on Cancer Drugs
U.S. efforts to encourage transparency widely ignored by companies
FDA’s Breakthrough Program: Faster Drug OKs Without Sacrificing Safety
Dedicated FDA staff guide companies during design of clinical trials
Mandated Disclosure of Clinical Trials Ignored — Especially for Competitive Drugs
Pharma companies less likely to disclose critical drug information than public institutions
Academic Medical Centers Resilient After Cuts
Following Medicare reimbursement rate changes, research actually increased
How Publicly Funded Research Leads to Cancer Drug Trials
Pharmaceutical companies are better able to identify promising new applications for existing drugs